The Top 10 hospitals for pediatric cardiology | Lung ultrasound before PCI | The most expensive CV drug in US history

Such attributes as patient outcomes, efficiency and available resources were used to develop the list, which includes a tie at No. 10. 

Adding lung ultrasound to a STEMI patient’s Killip classification leads to a more thorough, effective assessment, according to new findings published in Circulation: Cardiovascular Imaging.

Tafamidis received FDA approval in May 2019 for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). It has a list price of $225,000 per year.

The VERTIS CV Study tracked the performance of ertugliflozin and a placebo in more than 8,000 adult T2D patients.

Outpatient prescriptions for azithromycin are associated with an increased risk of cardiovascular mortality, according to new research published in JAMA Network Open.

A cardiologist at the University of Chicago Medicine has performed the first cardioneural ablation in U.S. history, using it to “rewire” the heart of a patient suffering from vasovagal syncope.

The retail giant's first Arkansas location opened this month, along with a new location in Loganville, Georgia.